- Home
- IRIX vs CRIS Comparison
IRIX vs CRIS Comparison
Compare IRIX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRIX
- CRIS
- Stock Information
- Founded
- IRIX 1989
- CRIS 2000
- Country
- IRIX United States
- CRIS United States
- Employees
- IRIX N/A
- CRIS N/A
- Industry
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRIX Health Care
- CRIS Health Care
- Exchange
- IRIX Nasdaq
- CRIS Nasdaq
- Market Cap
- IRIX 20.2M
- CRIS 18.6M
- IPO Year
- IRIX 1996
- CRIS 2000
- Fundamental
- Price
- IRIX $1.04
- CRIS $1.30
- Analyst Decision
- IRIX
- CRIS Strong Buy
- Analyst Count
- IRIX 0
- CRIS 2
- Target Price
- IRIX N/A
- CRIS $16.50
- AVG Volume (30 Days)
- IRIX 36.0K
- CRIS 80.8K
- Earning Date
- IRIX 11-11-2025
- CRIS 11-06-2025
- Dividend Yield
- IRIX N/A
- CRIS N/A
- EPS Growth
- IRIX N/A
- CRIS N/A
- EPS
- IRIX N/A
- CRIS N/A
- Revenue
- IRIX $49,744,000.00
- CRIS $11,650,000.00
- Revenue This Year
- IRIX $9.61
- CRIS $2.72
- Revenue Next Year
- IRIX N/A
- CRIS $8.27
- P/E Ratio
- IRIX N/A
- CRIS N/A
- Revenue Growth
- IRIX 0.09
- CRIS 13.56
- 52 Week Low
- IRIX $0.78
- CRIS $1.02
- 52 Week High
- IRIX $1.95
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- IRIX 42.91
- CRIS 26.64
- Support Level
- IRIX $1.00
- CRIS $1.46
- Resistance Level
- IRIX $1.10
- CRIS $1.49
- Average True Range (ATR)
- IRIX 0.04
- CRIS 0.09
- MACD
- IRIX 0.01
- CRIS -0.02
- Stochastic Oscillator
- IRIX 38.49
- CRIS 19.15
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.